Human Molecular Genetics, Vol 8, 237-245, Copyright © 1999 by Oxford University Press
P Kehoe, F Wavrant-De Vrieze, R Crook, WS Wu, P Holmans, I Fenton, G Spurlock, N Norton, H Williams, N Williams, S Lovestone, J Perez-Tur, M Hutton, MC Chartier-Harlin, S Shears, K Roehl, J Booth, W Van Voorst, D Ramic, J Williams, A Goate, J Hardy and MJ Owen
We have genotyped 292 affected sibling pairs (ASPs) with Alzheimer's
disease (AD) according to NINCDS-ADRDA diagnostic criteria and with onset
ages of >/=65 years using 237 microsatellite markers separated by an
average distance of 16.3 cM. Data were analysed by SPLINK and MAPMAKER/SIBS
on the whole sample of 292 ASPs and subsets of 162 ASPs where both members
possessed an apolipoprotein E (APOE)straightepsilon4 allele and 63 pairs
where neither possessed anstraightepsilon4 allele. Sixteen peaks with a
multipoint lod score (MLS) >1 either in the whole sample, the
straightepsilon4-positive or -negative subgroups were observed on
chromosomes 1 (two peaks), 2, 5, 6, 9 (two peaks), 10 (two peaks), 12, 13,
14, 19, 21 and X (two peaks). Simulation studies revealed that these
findings exceeded those expected by chance, although many are likely to be
false positives. The highest lod scores on chromosomes 1 (MLS 2.67), 9 (MLS
2.38), 10 (MLS 2.27) and 19 (MLS 1.79) fulfilLander and Kruglyak's
definition of 'suggestive' in that they would be expected to occur by
chance once or less per genome scan. Several other peaks were only
marginally less significant than this, in particular those on chromosomes
14 (MLS 2.16), 5 (MLS 2.00), 12, close to alpha2-macroglobulin (MLS 1.91),
and 21, close to amyloid precursor protein (MLS 1.77). This is the largest
genome scan to date in AD and shows for the first time that this is a
genetically complex disorder involving several, perhaps many, genes in
addition to APOE. Moreover, our data will be of interest to those hoping to
identify positional candidate genes using information emerging from
neurobiological studies of AD.
ARTICLES
A full genome scan for late onset Alzheimer's disease
Neuropsychiatric Genetics Unit, Tenovus Building, University of Wales College of Medicine, Heath Park,Cardiff CF4 4XN, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. L. Hamshere, P. A. Holmans, D. Avramopoulos, S. S. Bassett, D. Blacker, L. Bertram, H. Wiener, N. Rochberg, R. E. Tanzi, A. Myers, et al. Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease Hum. Mol. Genet., November 15, 2007; 16(22): 2703 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. V. De Ferrari, A. Papassotiropoulos, T. Biechele, F. Wavrant De-Vrieze, M. E. Avila, M. B. Major, A. Myers, K. Saez, J. P. Henriquez, A. Zhao, et al. Common genetic variation within the Low-Density Lipoprotein Receptor-Related Protein 6 and late-onset Alzheimer's disease PNAS, May 29, 2007; 104(22): 9434 - 9439. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grupe, R. Abraham, Y. Li, C. Rowland, P. Hollingworth, A. Morgan, L. Jehu, R. Segurado, D. Stone, E. Schadt, et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants Hum. Mol. Genet., April 15, 2007; 16(8): 865 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guyant-Marechal, A. Rovelet-Lecrux, L. Goumidi, E. Cousin, D. Hannequin, G. Raux, C. Penet, S. Ricard, S. Mace, P. Amouyel, et al. Variations in the APP gene promoter region and risk of Alzheimer disease Neurology, February 27, 2007; 68(9): 684 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kimura, K. Kamino, M. Yamamoto, A. Nuripa, T. Kida, H. Kazui, R. Hashimoto, T. Tanaka, T. Kudo, H. Yamagata, et al. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between {beta}-amyloid production and tau phosphorylation in Alzheimer disease Hum. Mol. Genet., January 1, 2007; 16(1): 15 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Olarte, N. Schupf, J. H. Lee, M.-X. Tang, V. Santana, J. Williamson, P. Maramreddy, B. Tycko, and R. Mayeux Apolipoprotein E {varepsilon}4 and Age at Onset of Sporadic and Familial Alzheimer Disease in Caribbean Hispanics Arch Neurol, November 1, 2006; 63(11): 1586 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, R. Cheng, V. Santana, J. Williamson, R. Lantigua, M. Medrano, A. Arriaga, Y. Stern, B. Tycko, E. Rogaeva, et al. Expanded Genomewide Scan Implicates a Novel Locus at 3q28 Among Caribbean Hispanics With Familial Alzheimer Disease Arch Neurol, November 1, 2006; 63(11): 1591 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Lin, E. R. Martin, P. G. Bronson, C. Browning-Large, G. W. Small, D. E. Schmechel, K. A. Welsh-Bohmer, J. L. Haines, J. R. Gilbert, and M. A. Pericak-Vance Exploring the association of glyceraldehyde-3-phosphate dehydrogenase gene and Alzheimer disease. Neurology, July 11, 2006; 67(1): 64 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun, G. He, and W. Song BACE2, as a novel APP {theta}-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome FASEB J, July 1, 2006; 20(9): 1369 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kuwano, A. Miyashita, H. Arai, T. Asada, M. Imagawa, M. Shoji, S. Higuchi, K. Urakami, A. Kakita, H. Takahashi, et al. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease Hum. Mol. Genet., July 1, 2006; 15(13): 2170 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, F. Li, A. Bulloj, Y.-w. Zhang, G. Tong, Z. Zhang, F.-F. Liao, and H. Xu Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules FASEB J, June 1, 2006; 20(8): 1272 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
E R Martin, P G Bronson, Y-J Li, N Wall, R-H Chung, D E Schmechel, G Small, P-T Xu, J Bartlett, N Schnetz-Boutaud, et al. Interaction between the {alpha}-T catenin gene (VR22) and APOE in Alzheimer's disease J. Med. Genet., October 1, 2005; 42(10): 787 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jimenez-Escrig, E. Gomez-Tortosa, M. Baron, A. Rabano, M. Arcos-Burgos, L. G. Palacios, A. Yusta, P. Anta, I. Perez, M. Hierro, et al. A multigenerational pedigree of late-onset Alzheimer's disease implies new genetic causes Brain, July 1, 2005; 128(7): 1707 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D'Introno, V. Solfrizzi, A. M. Colacicco, C. Capurso, F. Torres, S. A. Capurso, A. Capurso, and F. Panza Polymorphisms in the Oxidized Low-Density Lipoprotein Receptor-1 Gene and Risk of Alzheimer's Disease J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2005; 60(3): 280 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, P. Nowotny, P. Holmans, S. Smemo, J. S. K. Kauwe, A. L. Hinrichs, K. Tacey, L. Doil, R. van Luchene, V. Garcia, et al. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family PNAS, November 2, 2004; 101(44): 15688 - 15693. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Helisalmi, B. Dermaut, M. Hiltunen, A. Mannermaa, M. Van den Broeck, M. Lehtovirta, A. M. Koivisto, S. Iivonen, M. Cruts, H. Soininen, et al. Possible association of nicastrin polymorphisms and Alzheimer disease in the Finnish population Neurology, July 13, 2004; 63(1): 173 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sleegers, G. Roks, J. Theuns, Y. S. Aulchenko, R. Rademakers, M. Cruts, W. A. van Gool, C. Van Broeckhoven, P. Heutink, B. A. Oostra, et al. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population Brain, July 1, 2004; 127(7): 1641 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Margallo-Lana, C. M. Morris, A. M. Gibson, A. L. Tan, D. W.K. Kay, S. P. Tyrer, B. P. Moore, and C. G. Ballard Influence of the amyloid precursor protein locus on dementia in Down syndrome Neurology, June 8, 2004; 62(11): 1996 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Iivonen, E. Corder, M. Lehtovirta, S. Helisalmi, A. Mannermaa, S. Vepsalainen, T. Hanninen, H. Soininen, and M. Hiltunen Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease Neurology, April 13, 2004; 62(7): 1170 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bertram and R. E. Tanzi Alzheimer's disease: one disorder, too many genes? Hum. Mol. Genet., April 1, 2004; 13(90001): R135 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ntais, A. Polycarpou, and J. P. A. Ioannidis Meta-Analysis of the Association of the Cathepsin D Ala224Val Gene Polymorphism with the Risk of Alzheimer's Disease: A HuGE Gene-Disease Association Review Am. J. Epidemiol., March 15, 2004; 159(6): 527 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-C Lambert, E Luedecking-Zimmer, S Merrot, A Hayes, U Thaker, P Desai, A Houzet, X Hermant, D Cottel, A Pritchard, et al. Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease J. Med. Genet., June 1, 2003; 40(6): 424 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Goodman and A. B. Pardee Evidence for defective retinoid transport and function in late onset Alzheimer's disease PNAS, March 4, 2003; 100(5): 2901 - 2905. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Farrer, A. Bowirrat, R. P. Friedland, K. Waraska, A. D. Korczyn, and C. T. Baldwin Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community Hum. Mol. Genet., February 15, 2003; 12(4): 415 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Blacker, L. Bertram, A. J. Saunders, T. J. Moscarillo, M. S. Albert, H. Wiener, R. T. Perry, J. S. Collins, L. E. Harrell, R. C.P. Go, et al. Results of a high-resolution genome screen of 437 Alzheimer's Disease families Hum. Mol. Genet., January 1, 2003; 12(1): 23 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Prasad, W. C. Cole, and K. C. Prasad Risk Factors for Alzheimer's Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment J. Am. Coll. Nutr., December 1, 2002; 21(6): 506 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-F. Lee, S. Shah, H. Li, C. Yu, W. Han, and G. Yu Mammalian APH-1 Interacts with Presenilin and Nicastrin and Is Required for Intramembrane Proteolysis of Amyloid-beta Precursor Protein and Notch J. Biol. Chem., November 15, 2002; 277(47): 45013 - 45019. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lovestone and J. Hardy Psychotic genes or forgetful ones? Neurology, July 9, 2002; 59(1): 11 - 12. [Full Text] [PDF] |
||||
![]() |
S. A. Bacanu, B. Devlin, K. V. Chowdari, S. T. DeKosky, V. L. Nimgaonkar, and R. A. Sweet Linkage analysis of Alzheimer disease with psychosis Neurology, July 9, 2002; 59(1): 118 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Lovestone and D M McLoughlin Protein aggregates and dementia: is there a common toxicity? J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. HOLMES Genotype and phenotype in Alzheimer's disease The British Journal of Psychiatry, February 1, 2002; 180(2): 131 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Meschia, R. D. Brown Jr, T. G. Brott, J. Hardy, E. J. Atkinson, and P. C. O'Brien Feasibility of an Affected Sibling Pair Study in Ischemic Stroke: Results of a 2-Center Family History Registry Stroke, December 1, 2001; 32(12): 2939 - 2941. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hiltunen, A. Mannermaa, D. Thompson, D. Easton, M. Pirskanen, S. Helisalmi, A. M. Koivisto, M. Lehtovirta, M. Ryynanen, and H. Soininen Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland Neurology, November 13, 2001; 57(9): 1663 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bertram, D. Blacker, K. Mullin, D. Keeney, J. Jones, S. Basu, S. Yhu, M. G. McInnis, R. C. P. Go, K. Vekrellis, et al. Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10q Science, December 22, 2000; 290(5500): 2302 - 2303. [Abstract] [Full Text] |
||||
![]() |
N. Ertekin-Taner, N. Graff-Radford, L. H. Younkin, C. Eckman, M. Baker, J. Adamson, J. Ronald, J. Blangero, M. Hutton, and S. G. Younkin Linkage of Plasma A{beta}42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease Pedigrees Science, December 22, 2000; 290(5500): 2303 - 2304. [Abstract] [Full Text] |
||||
![]() |
A. Myers, P. Holmans, H. Marshall, J. Kwon, D. Meyer, D. Ramic, S. Shears, J. Booth, F. W. DeVrieze, R. Crook, et al. Susceptibility Locus for Alzheimer's Disease on Chromosome 10 Science, December 22, 2000; 290(5500): 2304 - 2305. [Abstract] [Full Text] |
||||
![]() |
L. J. Whalley, J. M. Starr, R. Athawes, D. Hunter, A. Pattie, and I. J. Deary Childhood mental ability and dementia Neurology, November 28, 2000; 55(10): 1455 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Mah, G. Perry, M. A. Smith, and M. J. Monteiro Identification of Ubiquilin, a Novel Presenilin Interactor That Increases Presenilin Protein Accumulation J. Cell Biol., November 13, 2000; 151(4): 847 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Finckh, H. von der Kammer, J. Velden, T. Michel, B. Andresen, A. Deng, J. Zhang, T. Muller-Thomsen, K. Zuchowski, G. Menzer, et al. Genetic Association of a Cystatin C Gene Polymorphism With Late-Onset Alzheimer Disease Arch Neurol, November 1, 2000; 57(11): 1579 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Theuns and C. Van Broeckhoven Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility Hum. Mol. Genet., October 1, 2000; 9(16): 2383 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Meschia, T. G. Brott, F. E. Chukwudelunzu, J. Hardy, R. D. Brown Jr, I. Meissner, L. J. Hall, E. J. Atkinson, and P. C. O'Brien Verifying the Stroke-Free Phenotype by Structured Telephone Interview Stroke, May 1, 2000; 31(5): 1076 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Theuns, J. Del-Favero, B. Dermaut, C. M. v. Duijn, H. Backhovens, M. V. d. Broeck, S. Serneels, E. Corsmit, C. V. Broeckhoven, and M. Cruts Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression Hum. Mol. Genet., February 12, 2000; 9(3): 325 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Alvarez, V. Alvarez, C. H Lahoz, C. Martinez, J. Pena, J. M Sanchez, L. M Guisasola, J. Salas-Puig, G. Moris, J. A Vidal, et al. Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, December 1, 1999; 67(6): 733 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Saunders, T. Kim, R. E. Tanzi;, W. Fan, B. D. Bennett, S. Babu-Kahn, Y. Luo, J. Louis, M. McCaleb, M. Citron, et al. BACE Maps to Chromosome 11 and a BACE Homolog, BACE2, Reside in the Obligate Down Syndrome Region of Chromosome 21 Science, November 12, 1999; 286(5443): 1255a - 1255. [Abstract] [Full Text] |
||||
![]() |
J. B. Martin Molecular Basis of the Neurodegenerative Disorders N. Engl. J. Med., June 24, 1999; 340(25): 1970 - 1980. [Full Text] [PDF] |
||||
![]() |
E. A. Eckman, D. K. Reed, and C. B. Eckman Degradation of the Alzheimer's Amyloid beta Peptide by Endothelin-converting Enzyme J. Biol. Chem., June 29, 2001; 276(27): 24540 - 24548. [Abstract] [Full Text] [PDF] |
||||
















